These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36876758)

  • 1. Bempedoic Acid and the Prevention of Cardiovascular Disease.
    Keaney JF
    N Engl J Med; 2023 Apr; 388(15):1427-1430. PubMed ID: 36876758
    [No Abstract]   [Full Text] [Related]  

  • 2. Benefits of Bempedoic Acid - Clearer Now.
    Alexander JH
    N Engl J Med; 2023 Apr; 388(15):1425-1426. PubMed ID: 36876748
    [No Abstract]   [Full Text] [Related]  

  • 3. A place for bempedoic acid: an effective therapeutic cooperation.
    Sbrana F; Dal Pino B; Bigazzi F; Sampietro T
    J Cardiovasc Med (Hagerstown); 2023 Jan; 24(1):75. PubMed ID: 36574303
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk.
    Wilkins JT; Lloyd-Jones DM
    JAMA; 2021 Jul; 326(3):266-267. PubMed ID: 34283191
    [No Abstract]   [Full Text] [Related]  

  • 5. Bempedoic acid as adjunct for traditional lipid-lowering therapy in patients with hyperlipidaemia.
    Schimmenti C; Sucato V; Manzone E; Cancellieri G; Mortillaro F; Novo G; Galassi AR; Venturella F
    Coron Artery Dis; 2021 Jun; 32(4):340-344. PubMed ID: 33229935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intolerance.
    Nicholls S; Lincoff AM; Bays HE; Cho L; Grobbee DE; Kastelein JJ; Libby P; Moriarty PM; Plutzky J; Ray KK; Thompson PD; Sasiela W; Mason D; McCluskey J; Davey D; Wolski K; Nissen SE
    Am Heart J; 2021 May; 235():104-112. PubMed ID: 33470195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of the Safety and Efficacy of Bempedoic Acid.
    Khan MU; Khan MZ; Munir MB; Balla S; Khan SU
    Am J Cardiol; 2020 Sep; 131():130-132. PubMed ID: 32711805
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia.
    Banach M; Duell PB; Gotto AM; Laufs U; Leiter LA; Mancini GBJ; Ray KK; Flaim J; Ye Z; Catapano AL
    JAMA Cardiol; 2020 Oct; 5(10):1124-1135. PubMed ID: 32609313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study.
    Ballantyne CM; Banach M; Mancini GBJ; Lepor NE; Hanselman JC; Zhao X; Leiter LA
    Atherosclerosis; 2018 Oct; 277():195-203. PubMed ID: 29910030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bempedoic acid: a CLEAR therapeutic option for statin-intolerant patients?
    Volpe M; Patrono C
    Eur Heart J; 2023 Jun; 44(21):1860-1861. PubMed ID: 37032425
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of bempedoic acid for prevention of cardiovascular events and diabetes: a systematic review and meta-analysis.
    Wang X; Zhang Y; Tan H; Wang P; Zha X; Chong W; Zhou L; Fang F
    Cardiovasc Diabetol; 2020 Aug; 19(1):128. PubMed ID: 32787939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bempedoic Acid for High-Risk Primary Prevention of Cardiovascular Disease: Not a Statin Substitute but a Good Plan B.
    Kazi DS
    JAMA; 2023 Jul; 330(2):123-125. PubMed ID: 37354548
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial.
    Goldberg AC; Leiter LA; Stroes ESG; Baum SJ; Hanselman JC; Bloedon LT; Lalwani ND; Patel PM; Zhao X; Duell PB
    JAMA; 2019 Nov; 322(18):1780-1788. PubMed ID: 31714986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bempedoic acid for the treatment of hypercholesterolemia.
    Yang J
    Expert Rev Cardiovasc Ther; 2020 Jul; 18(7):373-380. PubMed ID: 32532162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bempedoic acid: A new player in lipid-lowering therapies.
    Cuevas A; Alonso R
    J Clin Lipidol; 2020; 14(5):615-616. PubMed ID: 32988798
    [No Abstract]   [Full Text] [Related]  

  • 16. A Meta-Analysis of Cardiovascular Outcomes in Patients With Hypercholesterolemia Treated With Bempedoic Acid.
    Asbeutah AAA; Asbeutah SA; Abu-Assi MA
    Am J Cardiol; 2020 Oct; 132():166-168. PubMed ID: 32713651
    [No Abstract]   [Full Text] [Related]  

  • 17. Bempedoic Acid Reduces Major Adverse Cardiovascular Events for Statin-Intolerant Patients.
    Cunningham JM; Kiazand M
    J Gen Intern Med; 2024 Jun; 39(8):1536-1538. PubMed ID: 38575847
    [No Abstract]   [Full Text] [Related]  

  • 18. Bempedoic Acid: First Approval.
    Markham A
    Drugs; 2020 May; 80(7):747-753. PubMed ID: 32314225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bempedoic acid prevents cardiovascular events in statin-intolerant patients.
    Lim GB
    Nat Rev Cardiol; 2023 May; 20(5):285. PubMed ID: 36944785
    [No Abstract]   [Full Text] [Related]  

  • 20. Updated clinical evidence and place in therapy of bempedoic acid for hypercholesterolemia: ANMCO position paper.
    Colivicchi F; Di Fusco SA; Scicchitano P; Caldarola P; Murrone A; Valente S; Urbinati S; Roncon L; Amodeo V; Aspromonte N; Cipriani M; Domenicucci S; Francese GM; Imazio M; Scotto di Uccio F; Di Lenarda A; Gulizia MM; Gabrielli D
    J Cardiovasc Med (Hagerstown); 2021 Mar; 22(3):162-171. PubMed ID: 32842050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.